Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Phase I
Sort By
Newest First
1 / 1
1 / 1
MDD
Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study for Major Depressive Disorder
Firefly Neuroscience
PR-10-24-NI-46
Oct 16, 2024
Translational Medicine
PPD’s Approach to Practical Translational Medicine
Jeffrey Wheeler; Darin Brimhall, D.O., FACP
PPD, part of Thermo Fisher Scientific
PAO-11-21-CL-03
Nov 10, 2021
COVID-19 Vaccine
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
Pfizer
PR-M06-20-NI-042
Jul 02, 2020
Coronavirus
Moderna Announces First Participant Dosed in Phase 1 Study of mRNA Vaccine Against Novel Coronavirus
Moderna
PR-M03-20-NI-025
Mar 17, 2020
Positive Results
Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944)
Moderna
PR-M09-19-NI-039
Sep 16, 2019
Vaccines
Moderna Announces Publication of Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains
Moderna
PR-M05-19-NI-041
May 14, 2019
Sequencing
Gencove Announces Phase I SBIR Grant to Validate Polygenic Risk Score Estimation from Low-Pass Sequencing
Gencove
PR-M04-19-NI-092
Apr 30, 2019
Phase I
Kazia Presents Positive Cantrixil Phase I Data at AACR Conference
Kazia Therapeutics Limited
PR-M04-19-NI-022
Apr 05, 2019
Legislation
“Right To Try” Now Legal Across State Lines
Marc Technow
Nice Insight
PAO-M05-18-NI-026
Jun 01, 2018
Clinical Trials
Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft™C9T1 Skin Tissue
Mallinckrodt Pharmaceuticals
PR-M02-18-NI-74
Feb 20, 2018
Treatment
First Treatment for MERS Appears Safe in NIH Phase I Clinical Trial
SAB Biotherapeutics, Inc.
PR-M01-18-NI-041
Jan 15, 2018
Clinical Trial
Zika Vaccine Candidate Enters Phase I Trial
Nigel Walker
Nice Insight
PAO-M12-17-NI-008-5007
Dec 05, 2017
